Ebola has tortured us. People are dying very fast.
In the eastern reaches of the Democratic Republic of Congo, a rare and lethal strain of Ebola called Bundibugyo is spreading through a region already fractured by war and mistrust, prompting the World Health Organization to elevate its risk assessment to 'very high' at the national level. With 177 suspected deaths, no proven vaccine, and hospitals under attack, the outbreak tests not only the limits of medicine but the deeper human capacity to extend trust and cooperation in the face of terror. The crisis has crossed into Uganda, and while the world's risk remains low for now, the distance between containment and catastrophe is measured in both science and solidarity.
- A rare Ebola strain with a one-in-three fatality rate is spreading through DR Congo's conflict-torn Ituri province, where no proven vaccine exists to stop it.
- Violence is fracturing the response — isolation tents have been set ablaze, hospitals attacked, and healthcare workers placed under military guard as fear overtakes communities.
- The outbreak has crossed borders, with confirmed cases and a death recorded in Uganda among travelers from the DRC, raising the stakes for the wider region.
- Two experimental vaccines are racing through development, but the most promising candidate is still six to nine months from being ready for human testing.
- WHO has declared a public health emergency of international concern and is urging trust-building as the critical missing ingredient in an already overwhelmed response.
On Friday, the World Health Organization elevated the Ebola outbreak risk in the Democratic Republic of Congo from 'high' to 'very high' at the national level, a formal signal that the greatest danger — and the greatest need for resources — is concentrated there. Across the African region, the risk remains 'high'; globally, it is still assessed as 'low.'
The outbreak involves the Bundibugyo strain, a rare species of Ebola that kills roughly one in three people it infects. While 82 cases have been confirmed with seven confirmed deaths, the suspected toll is far heavier: 750 cases and 177 deaths across the country. Two confirmed cases have also emerged in Uganda, both linked to travelers from the DRC, though that situation is currently described as stable.
What makes this outbreak especially alarming is the absence of any proven vaccine for Bundibugyo. Effective tools exist for other Ebola strains, but not this one. Two candidates are in development — one built on the AstraZeneca Covid platform is undergoing animal testing in Oxford, with the Serum Institute of India prepared to manufacture it at scale. A second, described by WHO advisers as the most promising option, remains six to nine months from being ready for human trials.
The outbreak is centered in Ituri province near Bunia, a region already torn by armed conflict and deep institutional mistrust. Some cases have appeared in rebel-held territory. At one hospital near Bunia, a crowd attacked the facility, threw projectiles, and burned isolation tents, forcing police to fire warning shots. Medical workers now operate under military protection.
Community fear is real and visible. Residents describe watching neighbors die rapidly, and the practice of safe burial — essential to preventing transmission from highly infectious bodies — has become a flashpoint of resistance. WHO director Tedros Adhanom Ghebreyesus stressed that rebuilding trust is as vital as any medical intervention. A rare, lethal virus with no vaccine, spreading through a war zone where hospitals are under siege, is precisely what has pushed the world's leading health body to its most urgent warning short of a pandemic.
On Friday, the World Health Organization made an official shift in how it assessed the danger unfolding in the Democratic Republic of Congo. The risk from the current Ebola outbreak moved from "high" to "very high" at the national level, according to WHO director Tedros Adhanom Ghebreyesus. Across the wider African region, the assessment remained "high." Globally, for now, it stayed "low." The distinction matters because it signals where the organization believes the greatest threat lies—and where resources should flow.
The outbreak involves a rare strain called Bundibugyo, a species of Ebola that kills roughly one in three people it infects. As of Friday's briefing, 82 cases had been confirmed in the DRC, with seven confirmed deaths. But the suspected toll was far grimmer: 177 deaths and 750 suspected cases across the country. Two confirmed cases had also appeared in neighboring Uganda, including one death, both traced to people who had traveled from the DRC. The situation in Uganda was described as stable.
What makes Bundibugyo particularly menacing is the absence of a proven vaccine. The world has effective tools against other Ebola species—Ervebo, for instance, works against the more common Zaire strain—but nothing yet exists for this variant. Two vaccine candidates are in development. One, built on the same platform that produced the AstraZeneca Covid vaccine, is already undergoing animal testing in Oxford. The Serum Institute of India stands ready to manufacture it at scale once Oxford can provide medical-grade material, though there are no guarantees the vaccine will prove effective until human trials are complete. A separate experimental vaccine, described by WHO research adviser Vasee Moorthy as "the most promising" option, is expected to take six to nine months before any doses are ready for testing.
The outbreak is centered in Ituri province, near the city of Bunia, where nearly all cases have been reported. But the region where it is spreading is fractured by conflict and mistrust. On Sunday, the WHO declared a public health emergency of international concern—though not yet a pandemic. What complicates the response is not just the virus itself but the environment in which it spreads. Violence and insecurity are hampering containment efforts. Some confirmed cases have emerged in rebel-held areas. At Rwampara General Hospital, near Bunia, a crowd threw projectiles at the facility and set fire to isolation tents, forcing police to fire warning shots to restore order. Medical workers were placed under military protection.
The fear gripping affected communities is palpable and understandable. A young taxi driver in Rwampara told the BBC that people were dying rapidly and that terror had taken hold. Another resident, Fred Kiza, acknowledged that such fear was natural when facing a disease of this severity. The challenge of safe burial—essential to preventing transmission from deceased victims, whose bodies remain highly infectious—has become another flashpoint. Authorities must convince communities to allow proper handling of the dead, a task made harder by the violence and the breakdown of trust in institutions.
Tedros emphasized on Friday that building trust would be crucial to controlling the outbreak. The virus itself is straightforward in its biology: it normally infects animals, typically fruit bats, and human outbreaks can begin when people eat or handle infected animals. But stopping its spread requires not just medical knowledge but also the cooperation of frightened, sometimes hostile populations in a region already torn by war. That combination—a rare, deadly virus with no proven vaccine, spreading through a conflict zone where hospitals are under attack—is what has pushed the WHO's risk assessment to "very high."
Notable Quotes
We are now revising our risk assessment to very high at the national level, high at the regional level, and low at the global level.— WHO director Tedros Adhanom Ghebreyesus
They started throwing projectiles at the hospital. They even set fire to tents that were being used as isolation wards.— Luc Malembe Malembe, local politician, describing violence at Rwampara General Hospital
The Hearth Conversation Another angle on the story
Why does it matter that this is the Bundibugyo strain and not Zaire?
Bundibugyo is rare, which means we have almost no experience fighting it. We have a vaccine for Zaire that works. For Bundibugyo, we're starting from scratch. And it kills about one in three people—that's a high fatality rate.
The WHO said the global risk is still "low." How do they square that with 177 suspected deaths?
They're distinguishing between where the outbreak is happening and where it's likely to spread. Right now it's concentrated in eastern DRC. The global assessment reflects the belief that it won't easily jump continents—but that could change if cases appear in major travel hubs.
What's the actual barrier to getting a vaccine ready?
Time and uncertainty. One candidate is in animal testing now, but even if it works in animals, human trials take months. The other promising vaccine needs six to nine months just to produce a testable dose. You can't skip those steps.
The violence at the hospital—is that a separate problem or part of the outbreak response?
It's part of it. People are scared and mistrustful. When you're in a war zone and a disease appears, institutions have already lost credibility. So people resist isolation, resist safe burial practices. The virus spreads faster in that chaos.
Why does safe burial matter so much?
A dead body infected with Ebola is extremely infectious. If families handle the body without protection, or if it's buried improperly, the virus can spread to others. It's one of the main transmission routes in outbreaks. But convincing grieving families to let authorities handle their dead—that requires trust the region doesn't have right now.
What happens in the next six months?
Either the outbreak is contained through isolation and contact tracing, or cases keep spreading. The vaccines being developed could help, but they won't arrive in time to stop this wave. The real question is whether the violence stops and whether people start cooperating with health workers.